5966 related articles for article (PubMed ID: 2470106)
41. Monoclonal anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen: generation and characterization of anti-idiotype antibodies.
Chattopadhyay P; Sneed D; Rosenberg J; Starkey J; Robertson N; Leonard J; Raychaudhuri S
Cancer Res; 1991 Jun; 51(12):3183-92. PubMed ID: 1710168
[TBL] [Abstract][Full Text] [Related]
42. Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal anticarcinoma antibody.
Hellström KE; Yelton DE; Fell HP; Beaton D; Gayle M; MacLean M; Kahn M; Hellström I
Cancer Res; 1990 Apr; 50(8):2449-54. PubMed ID: 1690598
[TBL] [Abstract][Full Text] [Related]
43. Chimeric antibodies with specificity for tumor antigens: demonstration of in situ localization to tumors after antibody therapy.
Saleh MN; Tilden AB; Meredith RF; LoBuglio AF; Grizzle WE
Biotech Histochem; 1998 Jul; 73(4):186-97. PubMed ID: 9735877
[TBL] [Abstract][Full Text] [Related]
44. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
[TBL] [Abstract][Full Text] [Related]
45. Serological characterization of a shared melanoma-associated antigen of mouse melanomas: relationship to the B700 glycoprotein.
DeLeo AB; Hearing VJ; Vieira WD; Law LW
Melanoma Res; 1991; 1(2):133-40. PubMed ID: 1668533
[TBL] [Abstract][Full Text] [Related]
46. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
[TBL] [Abstract][Full Text] [Related]
47. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody.
Mueller BM; Romerdahl CA; Gillies SD; Reisfeld RA
J Immunol; 1990 Feb; 144(4):1382-6. PubMed ID: 2303711
[TBL] [Abstract][Full Text] [Related]
49. Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.
Hwang KM; Fodstad O; Oldham RK; Morgan AC
Cancer Res; 1985 Sep; 45(9):4150-5. PubMed ID: 4028007
[TBL] [Abstract][Full Text] [Related]
50. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
51. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
[TBL] [Abstract][Full Text] [Related]
52. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
53. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
Xiang J; Moyana T; Kalra J; Hamilton T; Qi Y
Mol Biother; 1992 Dec; 4(4):174-83. PubMed ID: 1476671
[TBL] [Abstract][Full Text] [Related]
54. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
55. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
Chen ZJ; Yang H; Kageshita T; Ferrone S
Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
[TBL] [Abstract][Full Text] [Related]
56. Identification of the human melanoma-associated chondroitin sulfate proteoglycan antigen epitope recognized by the antitumor monoclonal antibody 763.74 from a peptide phage library.
Geiser M; Schultz D; Le Cardinal A; Voshol H; García-Echeverría C
Cancer Res; 1999 Feb; 59(4):905-10. PubMed ID: 10029083
[TBL] [Abstract][Full Text] [Related]
57. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen.
Imai K; Pellegrino MA; Wilson BS; Ferrone S
Cell Immunol; 1982 Sep; 72(2):239-47. PubMed ID: 6185235
[No Abstract] [Full Text] [Related]
58. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope.
Martin F; Kupsch J; Takeuchi Y; Russell S; Cosset FL; Collins M
Hum Gene Ther; 1998 Mar; 9(5):737-46. PubMed ID: 9551621
[TBL] [Abstract][Full Text] [Related]
59. D6.1, a murine antimelanoma monoclonal antibody from congenitally athymic nude mice immunized with purified melanoma tumor-associated antigen.
Stuhlmiller GM; Borowitz MJ; Seigler HF
Hybridoma; 1984; 3(4):333-46. PubMed ID: 6396196
[TBL] [Abstract][Full Text] [Related]
60. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
Wilson BS; Petrella E; Lowe SR; Lien K; Mackensen DG; Gridley DS; Stickney DR
Cancer Res; 1990 May; 50(10):3124-30. PubMed ID: 2159374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
